Structure-Function of Entamoeba Alcohol Dehydrogenase 2
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
批准号:
6890407
负责人:
SAMUEL L. STANLEY
金额:
$30.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-01 至 2007-04-30
关键词:
DNA binding proteinHaemophilus influenzaeHeLa cellsbiological signal transductionchronic obstructive pulmonary diseaseglucocorticoidshormone regulation /control mechanismimmunofluorescence techniqueimmunoprecipitationinflammationintracellular transportmicroorganism culturemitogen activated protein kinasemolecular pathologynuclear factor kappa betaotitis mediapathologic processpolymerase chain reactionprotein protein interactionreceptor expressionrespiratory epitheliumrespiratory infectionssecondary infectiontoll like receptortransfectionwestern blottings
中文摘要
非分型流感嗜血杆菌(NTHi)可引起慢性阻塞性肺疾病(COPD)和中耳炎(OM)的感染。两者都以炎症为特征。NTHi诱导炎症的分子机制仍不清楚。我们的长期目标是了解在NTHi感染中诱导和调节炎症反应的分子机制。我们最近的研究表明,NTHi通过新近发现的细菌受体Toll样受体2(TLR2)激活核因子-kappaB(NF-kappaB)。由于TLR2在呼吸道上皮细胞中低表达,过表达TLR2可显著增强NTHi诱导的NF-kappaB活性,我们推测NTHi通过特定的信号网络上调TLR2。我们的初步结果确实表明,NTHi通过正的NF-kappaB途径和负的p38MAPK途径强烈上调TLR2。此外,糖皮质激素可协同增强NTHi诱导的TLR2上调。这些令人鼓舞的结果为进一步研究NTHi诱导TLR2上调的分子机制奠定了坚实的基础(短期目标)。目的1.通过干扰核因子-kappaB信号通路,确定核因子-kappaB的激活在NTHi诱导的TLR2上调中的作用。目的2.通过干扰p38信号通路,确定p38 MAPK信号通路在NTHi诱导的TLR2上调中的作用。目的3.通过研究糖皮质激素对NTHi诱导的p38通路激活的影响,探讨糖皮质激素协同增强NTHi诱导的TLR2上调的信号机制。意义:了解NTHi诱导TLR2上调的信号机制不仅将为炎症的调控带来新的见解,而且将为调节COPD和OM的炎症反应开辟新的治疗靶点。此外,阐明糖皮质激素促进NTHi诱导的TLR2上调的分子机制将为如何在临床上更恰当地使用糖皮质激素提供有益的信息。
英文摘要
Nontypeable Haemophilus influenzae (NTHi) causes infections in chronic obstructive pulmonary disease (COPD) and otitis media (OM). Both are characterized by inflammation. The molecular mechanisms underlying NTHi-induced inflammation remain poorly defined. Our long-term objective is to understand the molecular mechanisms by which the inflammatory response is induced and regulated in NTHi infections. Our recent studies showed that NTHi strongly activates nuclear factor-kappaB (NF- kappaB) via Toll-like Receptor 2 (TLR2), a newly identified receptor for bacteria. Because TLR2 expression in airway epithelial cells is low and overexpression of TLR2 greatly enhances NTHi-induced NF-kappaB activation, we hypothesize that NTHi up-regulates TLR2 via a specific signaling network. Our preliminary results indeed indicate that NTHi strongly up- regulates TLR2 via a positive NF-kappaB pathway and a negative p38 MAPK pathway. Moreover, glucocorticoids synergistically- enhance NTHi-induced TLR2 up-regulation. These encouraging results have thus laid a solid foundation for further investigation of the molecular mechanisms underlying NTHi-induced TLR2 up-regulation (short-term objective). Aim 1. Determine the contribution of NF-kappaB activation to NTHi-induced TLR2 up- regulation by perturbing NF-kappaB signaling pathways. Aim 2. Determine the contribution of p38 MAPK signaling pathway to NTHi- induced TLR2 up-regulation by perturbing p38 signaling pathway. Aim 3. Determine the signaling mechanisms by which glucocorticoids synergistically enhance NTHi-induced TLR2 up- regulation by studying the effect of glucocorticoids on NTHi- induced activation of p38 pathway. Significance: Understanding the signaling mechanisms underlying NTHi-induced TLR2 up- regulation will not only bring new insights into the regulation of inflammation, but will also open up novel therapeutic targets for modulating inflammatory responses in COPD and OM. Moreover, elucidating the molecular mechanisms by which glucocorticoids enhance NTHi-induced TLR2 up-regulation will provide instructive information regarding how to use glucocorticoids more appropriately in the clinic.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
An Animal Biosafety Level 3 Laboratory for Stony Brook University
-
批准号:7872073
-
项目类别:
-
资助金额:$1417.96万
-
财政年份:2010
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE Administrative Core
-
批准号:7641628
-
项目类别:
-
资助金额:$55.86万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Overall Career Development
-
批准号:7641691
-
项目类别:
-
资助金额:$66.24万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Immunogenetics of Smallpox Vaccination
-
批准号:7641580
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases (Development Projects)
-
批准号:7641692
-
项目类别:
-
资助金额:$62.03万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6698909
-
项目类别:
-
资助金额:$334.38万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6908968
-
项目类别:
-
资助金额:$827.51万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:7020077
-
项目类别:
-
资助金额:$795.37万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6797835
-
项目类别:
-
资助金额:$789.41万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:7594903
-
项目类别:
-
资助金额:$798.22万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:7207962
-
项目类别:
-
资助金额:$766.08万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6733593
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6466309
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6623491
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
ENTAMEBA HISTOLYTICA ADH2--A NEW TARGET FOR ANTI-AMEBIC THERAPY
-
批准号:6099926
-
项目类别:
-
资助金额:$10.76万
-
财政年份:1998
-
负责人:SAMUEL L. STANLEY
-
依托单位:
ENTAMEBA HISTOLYTICA ADH2--A NEW TARGET FOR ANTI-AMEBIC THERAPY
-
批准号:6235345
-
项目类别:
-
资助金额:$9.83万
-
财政年份:1997
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2671354
-
项目类别:
-
资助金额:$6.47万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2057405
-
项目类别:
-
资助金额:$6.35万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2517109
-
项目类别:
-
资助金额:$6.43万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2057406
-
项目类别:
-
资助金额:$6.39万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
海外基金